ORIENTBIO Signs Exclusive Primate CRO Business Rights Agreement with OrientCam
ORIENTBIO has signed an exclusive business rights agreement with its affiliate OrientCam to expand their non-clinical research (CRO) business for research-use primates.
According to ORIENTBIO on July 15, under this contract, ORIENTBIO will utilize the primate production facilities owned by OrientCam to exclusively conduct its CRO business targeting domestic and international pharmaceutical, biotech companies, and research institutions.
ORIENTBIO will oversee client contracts, the execution of non-clinical trials, quality assurance (QA), regulatory compliance, data analysis, and the development of an AI-based non-clinical platform. OrientCam will be responsible for the breeding and production of primates. The companies plan to establish an integrated AI non-clinical platform, linking stable primate supply to the execution of non-clinical studies and data analysis.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A company representative stated, "This contract will be an important milestone that connects the primate production infrastructure of the Orient Group with ORIENTBIO's expertise in non-clinical trials. We will strengthen cooperation with domestic and international pharmaceutical, biotech companies, and research institutions and actively pursue overseas expansion to enhance the competitiveness of our primate CRO business."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.